Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health (NIH) has announced a funding opportunity titled "Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)" aimed at supporting projects that enhance the utility of selected NIH Common Fund data sets. The initiative seeks to fund small research applications that leverage data from at least two eligible Common Fund programs or utilize data from the Molecular Transducers of Physical Activity in Humans (MoTrPAC), with the goal of generating hypotheses, catalyzing discoveries, and gathering feedback on these resources. NIH plans to commit approximately $4 million in FY 2026, anticipating 10-13 awards with a maximum budget of $200,000 per project and a project period of one year. Interested applicants can reach out to CFDE@od.nih.gov for further information, and the application deadline is June 23, 2026.
Eligible Applicants
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.